22 May 2013
Keywords: alex, matter, head, novartis, institute, tropical, research
Article | 08 September 2003
Alex Matter, the Novartis scientist who spearheaded the discovery of the cancer treatment Glivec (imatinib), has been named the inaugural
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2003
21 May 2013
© 2013 thepharmaletter.com